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ABSTRACT
Title of thesis : Mathematical Modeling of The Unsteady
State Glucose and Insulin Concentrations
in Blood for Normal Subjects and Diabetics
Nane : Tung Shih, Master of Science
A mathematical model of the blood-glucose regulatory
system has been developed. This model describes an oral
glucose tolerance test adequately and simulates the behavior
of the real physiological system using computer techniques.
Regression of the rate constants involved have been
effected by conforming the theoretical functions to the data
from glucose tolerance test in nonobese normal subjects,
obese normal subjects, nonobese mild diabetics, obese mild
diabetics, nonobese moderate diabetics and obese moderate
diabetics measured by continuous sampling after oral
ingestion. Most of the data were conformed within the
limits of experimental error. The result of optimal
parameters lead to a criterion for separating normal subjects
from mild diabetics and moderate diabetics.
The significance of the model conformation is discussed
in view of the goals of modeling and the extension of
knowledge of blood-glucose mechanism in the human body.
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CHAPTER I
INTRODUCTION
Studies of blood glucose dynamics have attracted the
interest of persons with a variety of backgounds. Glucose
plays a essential role in the intermediary metabolism of
many tissues; both extremely high values and extremely low
values of blood glucose are associated with severe pathological symptoms. Thus, criterion, regulation, and control
of blood glucose levels are an essential function of the
organism.
The body's ability to maintain blood glucose at a
relatively constant concentration results from the complex
interrelationships between carbohydrate, lipid, and proteinmetabolism and various hormones. For the past several years,
several various simulations of the blood glucose regulatory
system have been performed. Mathematical models of such a
complex system represents an abstraction and a lumping of
many parameters into a relatively small number of empirically
determinable ones. The significance of the model conformations to glucose metabolism is discussed in view of kinetic
dynamics and process control. In 1961, V. Bolie suggested
a one-compartment model to illustrate the mathematical relationship between the kinetics of glucose and of insulin in
plasma. In 1964, E. Ackerme et. al. effectively adopted
Bolie's model and by the judicious selection of a mathematical

function to simulate gastro-intestinal abosrption endeavoured
to apply the model clinically in the interpretation of the
oral glucose tolerance test.
Ackerme's model gives a general valuation of the glucosetolerance curve for diagnostic purpose than the morphological
or semiquantitative criteria employed. Current physiologic
knowledge about glucose-insulin homeostasis in liver, brain,
pancreas, kidney, peripheral tissues, and central vascular
organs has been synthesized to form more accurate dynamics.
So, we attempt to develop a mathematical model to include
all available knowledge as possible and to map this in a
fashion which can represent the overall action of the system.
The model developed here is a set of simultaneous nonlinear
differential equations which cannot be solved analytically.
In our theorectial investigation we had three aims in
view,
I. To develop criteria (by the parameters of the model)
to distinguish the difference between normal and abnormal
responses.
2.

To find out how much information could be extracted

from the results of the test data as it is often carried out
clinically.
3.

To model and extend the knowledge of blood glucose

dynamics that enable us to understand the physiological
mechanism and control system.
Indeed, our initial interest arose from a desire to
combine the blood-glucose levels during the oral g ucosel
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tolerance test in a kinetic model which would lead to a criterion for separating normals from diabetics.
The results support the hypothesis that the natural
period measured can be used to distinguish health from disease.
The success of our mathematical model to distinguish the
losing function of the dynamic mechanism between normals and
diabetics through the judgment of parameters leads to determine the physiological sensitivity domination. It is quite
possible that such a criterion might have clinical utility.

CHAPTER II
DEVELOPMENT OF THE MATHEMATICAL MODEL
In originally selecting a mathematical model, the criteria used included simplicity and agreement with experimental oral glucose-tolerance data both in magnitude and form.
In the oral glucose-tolerance test, the subject eats a large
dose of glucose. The fasting concentration of blood glucose
is measured before the glucose is administered. Models for
glucose and insulin distribution in man were developed.
These are referred to as the Ackerman et al., 1964 and Norwich et al., 1969 respectly. In addition these, a book by
W. F. Ganong named "Review of Medical Physiology" describ the
mechanism of glucose and insulin in chapter 19. Figure 1
depicts in the form of a block diagram the response of the
body to added glucose. It is further apparent that these are
interlocked in a feedback loop, thereby making oscillations
possible. The diagram contain 16 physiological parameters,
a few of which are uncertain. However, this number 16 is
a minimum quantities since one would like to indicate, for
example, a different rate of glucose utilization in each
tissue and also the roles of other hormones and of the nervous system. The basic assumptions used in formulating this
overall description of the blood-glucose regulatory system
are simplifications of known interactions between glucose,
insulin, and other regulatory hormones to take explicit

account of the role of the adrenal cortical and medullary
function in glucose economy and of the heterogeneity of pancreatic insulin.
In chemicals and in physical mechanics, the technique
of lumping parameters has proved very useful. Figure 2 presents a system of our model in which the parameters of Figure
1 have been lumped into two dependent variables, (G) and (I),
seven rate constants. The blood-glucose level (G) can be
increased either by glucose from the intestines or intravenous
source, or by release of glucose from the liver. The bloodglucose level is decreased by removal of glucose by the liver
or other tissues of storage or metabolism. The insulin (I)
is assumed to promote the effect of accelerating glucose depletion. The simultaneous nonlinear differential equations
of which imply the lumped parameters for blood glucose and
insulin concentration are

(G) = Glucose concentration
(I) = Insulin concentration
K 1 (G) (I) = Mass transfer of glucose to peripheral tissue
which is dependent of insulin. This is a nonlinear term.
K (C)

=

Average rate of glucose transfer to brain or to
red cells which is independent of insulin,
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K

3

= A constant of average rate of release of glucose into
blood plasma from tissue or liver. (if (G) is much
lower than the fasting glucose concentration (G 0 ),
the extra glucose may be added by breaking down of
glycogen in liver or tissue)

M (t) = Input of glucose from glucose-insulin adsorption
1

(gastro-intertinal), and

t

1

: The time at which glucose concentration is
maximum.

K (I) = Mass transfer of insulin removal which is independent of glucose due to breakdown in plasma by
enzyme in 7 to 10 minutes.
K (G) = Extra secretion of release of insulin due to glu5
cose by a feedbck mechanism coming from pancreas.

Where K 6 represents insulin coming from β-cells of
pancreas to maintain constant influe of insulin and
K 7 represents a feedback due to step input of M

1

So, we can therefore express equations (1) and (2) as:
(a) During oral glucose input or meal,

6

(t).

(b) After a step function of glucose input, t 1 < t

There are few important notes we should discuss here:
(1) Glucose metabolizes by cycles in tissue (i.e. kerbs,
glycolysis, etc.), so we assume that no disappearance due to
reaction in plasma.
(2) Assuming M 1 (t) as a step function.
(3) Assuming (I) in equal with (I) ads which is adsorbed
on the surface of tissue especially on the liver.
There is wide variation in the values assumed by the rate
constants. These parameters in general fall into the "physiological" range and are all positive as required. Accordingly,
K

1 represents the lumped effect of the change of liver set-

point for glucose absorption and of the change of the rate of
glucose removal by the other tissues due to change in insulin.
Similarly, M 2 represents the tendency of the system to return
the blood glucose concentration towards its fasting value.
K

3 represents the extra glucose secretion to keep the fasting
glucose level. K 4 represents the tendency of the system to

return the net insulin towards the fasting value. K

5 repre-

sents the lumped effects of the stimulation of the endocrine
system protection of insulin from metabolic removal. The
constants K 3, K 6 , and K 7 are already explained previously.

7

Figure 1. Block-diagram representation of feedback loop
involved in glucose tolerance test. Question mark
indicate uncertain reactions.

8

Figure 2. Simplified block diagram representation of the mechanism of glucose tolerance
test.

CHAPTER III
EXPERIMENTS AND CURVE FITTING
Glucose tolerance test are a well known example of an
experiment designed to classify individuals according to
their response to a challenge load of glucose. These tests
are also helpful to evaluate the assumptions made in formulating the basic model concerning the regulation of blood.
(Gate Wood et. al., 1968)
In the oral glucose test, the subjects eats normal meals
for several days, as extreme diets can affect the results.
After an overlight fast, a blood sample is drawn. This is
the zero time taken as the instant of cessation of loading.
The subject then drink a glucose-enriched drink and several
intermittent blood samples are obtained at 0, 10, 20, 30, 45,

60, 90, 120, 150, 180, 210, and 240 minutes afterward. The
data published by H. S. Seltzer and colleagues who desired
quantitative comparison of oral and intravenous glucose administration in different kinds of subjects. The glucose
and insulin concentrations were classified in Table 1 and 2.
This test reveals the functioning of the overall physiological system, but abnormalities detected may be due to the
patterns of intestinal glucose absorption.
After we set up the mathematical model, the first goal
is data description. If we use parameters of our model to
reduce a mass of data to a small number of constraints
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TABLE 1
Blood glucose concentrations during oral glucose tolerance test
Minutes
0

10

20

30

45

60

90

120 150

180

210 240

mg/100ml
Normal subjects
Nonobese(21)

Mean
SEM

75
±1

86
±2

108
±3

113
±4

108
±6

98
±6

88
±3

82
±2

78
±3

77
±3

70
±4

70
±4

Obese(11)

Mean
SEM

77
±2

89
±4

110
±5

123
±30

126 116
±8
±8

99
±7

90
±5

93
±4

85
±8

76
±4

72
±3

±9

Mild diabetics
Nonobese(10)

Mean
SEM

80 100
±3
±7

135
±6

161
±6

185 201 182 155
±9 ±11 ±14 ±12

127
±14

108
±14

95
±12

Obese(11)

Mean
SEM

82
±3

122
±4

145

163 181

160
±9

144
±10

123
131
±12 ±13

96
±3

±4

±6

179 176

±6 ±10 ±12

77

Moderata diabetics
Nonobese(7)

Mean
SEM

137 153
±11
±9

172
±10

213
±9

251 284 295 294
±13 ±15 ±27 ±27

274
±27

254
±30

240 211
±32 ±42

Obese(7)

Mean
SEM

142 156
+12 ±11

189

223

259 290 313 315

295
±34

280
±34

251 212
±28 ±25

±13

±12

±18 ±21 ±22 ±29

TABLE 2
Blood insulin concentrations during oral glucose tolerance test
Minutes
0

10

20

30

45

60

90

120

150 180

210 240
μU/ml

Normal subjects
Nonobese(21)

Mean
SEM

11
±1

40
±7

93

111

±7

129
±10

122
±11

103

93
±16 ±14

89
±16

±15

52

45

Obese(11)

Mean
SEM

33

68 137

193

269

274

216 199

160
±31

117
72
±23 ±18

33
±4

178

140 107

61

±8

±2 ±14 ±16

±18

±37

±35

±39 ±37

70

±8

±8

Mild diabetics
Nonobese(10)
Obese(11)

Mean
SEM

9
±2

27
67
±5 ±14

113
±21

138

Mean
SEM

22
±2

38

116
±15

155
±20

±5

77
±8

±36

195

±35

200
±30

233 228

±42 ±39

± 31

200 202
±16 ±27

181
±23

-

±36 ±34 ±27

167 158 138
±20 ±19 ±28

Moderate diabetics

89

91

65

49

Nonobese(7)

Mean
SEM

19
±5

20
27
±4 ±11

28
±10

±18

±16

±25 ±29

±32

±28 ±20 ±17

Obese(7)

Mean
SEM

19
±7

20

47
±13

±17

55

69
±16

102
99
±33 ±30

111
±27

62
78
94
.±27 ±17 ±15

36

±4 ±11

54

59

95 103

are more amenable to human discussion, then the application
of the model serves a real purpose. This activity, sometimes
referred to as curve fitting, was the initial approach of this
thesis to models of blood glucose dynamics. For this purpose one asks that the selected model be capable of predicting
curves which pass within the limits of experimental error of
the observed values. The second goal which we looked for in
the studies of our model of the blood glucose regulation is
the possibility of using the derived parameters for diagnostic
classification. If the derived parameters can separate normal from abnormal, or can help to characterize quantitatively
disease states, then the model need not even produce an acceptable description of the empirical data.
Because our model is nonlinear differential equations,
we can not solve the equations analytically. So the fourth
order Runge-Kutta method is used to integrate our nonlinear
differential equations and gets the glucose and insulin concentrations for every minute. Then we use the least square
curve fitting procedure with the Rosenbrock Hillclimb regression program to get the optimal parameters of the model.
The computer program used an iterative guessing technique which required initial guesses for K 1 to K 7 . These
parameters were adjusted by the computer until the cumulative
sum of the squares of the derivation between the data points
and the calculated points was a minimum.
The regression algorithm of Rosenbrock's theory varied
all seven of the parameters in the neighborhood of the first
— 13 —

guess. The best neighboring point was then selected for the
second guess, and so forth. When a given point was found to
yield a lower cumulative sequare deviation than its neighbors,
the step-sizes to the neighboring points were reduced and
the entire process reiterated. When the step-size became
sufficiently small, the process was terminated.
In this fashion the program always found an estimated
set of values for the parameters yielding a least-square fit
between the model and the data. It is needed to emphasize
here, the initial guess of the parameters and the step-sizes
is very important and very sensitive. Because in a case of
bad guess, the program might converged to a local minimum
with a large cumulative squared deviations, or the program
was overflow, but suitable initial guesses enabled the model
to be successfully conformed to all the data. On the other
hand, a too large value of a step-size will lead to an overflow quickly due to the integration subroutine. We have to
choose a suitable step-size in consistency with the size of
the parameters which we guessed by trial. The optimization
procedures are the most difficult part of this thesis.
The fitted parameters, which could then be used to
describe each response qualitatively, and the glucose and insulin concentrations were printed out. Figure 3 to Figure
14 show the calculated curves and the data points. Most of
the theoretical values were conformed within the limits of
experimental error. The fitting of obese normal and nonobese
mild diabetics have some small deviations between the simu- 14 —

lated curves and the actual data. These situations can be
improved by a modified model.
All the parameters were checked for last twenty regration values to see if the parameters converge on the constant value eventually. The results of checking every parameter on every case show that the parameters do converge on
the steady values (Appendix B).
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Time in Minutes
FIG. 3. Comformation of the mathematical model(curves) to data
(points) obtained during an oral glucose tolerance test of glucose
concentration on nonobese normals.

Time in Minutes
FIG. 4. Comformation of the mathematical model(curve) to data
(points) obtained during an oral glucose tolerance test of insulin
concentration on nonobese normals

Time in Minutes
FIG. 5. Conformation of the mathematical model(curves) to data
(points) obtained during an oral glucose tolerance test of glucose
concentration on obese normals.

Time in Minutes
FIG. 6. Comformation of the mathematical model(curves) to data
(points) obtianed during an oral glucose tolerance test of insulin
concentration on obese normals.

Time in Minutes
FIG. 7. Comformation of the mathematical model(curves) to data
(points) obtained during an oral glucose tolerance test of glucose
concentration on nonobese mild diabetics.

Time in Minutes
FIG. 8. Comformation of the mathematical modle(curves) to data
(points) obtained during an oral glucose tolerance test of insulin
concentration on nonobese mild diabetics.

Time in Minutes
FIG. 9. Comformation of the mathematical model(curves) to data
(points) obtained during an oral glucose tolerance test of glucose
concentration on obese mild diabetics.

Time in Minutes
FIG. 10. Conformation of the mathematical model(curves) to data
(points) obtained during an oral glucose tolerance test of insulin
concentration on obese mild diabetics.

Time in Minutes
FIG. 11. Comformation of the mathematical modle(curves) to data
(points) obtianed during an oral glucose tolerance test of glucose
concentration on nonobese moderate diabetics.

Time in Minutes
FIG. 12. Comformation of the mathematical model(curves) to data
(points) obtained during an oral glucose tolerance test of insulin
concentration on nonobese moderate diabetics.

Time in Minutes
FIG. 13. Conformation of the mathematical model(curves) to data
(points) obtained during an oral glucose tolerance test of glucose
concentration on the obese moderate diabetics.

Time in Minutes
FIG. 14. Comformation of the mathematical modle(curves) to data
(points) obtained during an oral glucose tolerance test of insulin
concentration on obese moderate diabetics.

CHAPTER IV
RESULTS AND DISCUSSION
The result of the optimal parameters show the change of
dynamic mechanisms from normals to diabetics. The final
result are discussed as follow:
(I) Case of non-obese normal, non-obese mild diabetics and
non-obese moderate diabetics
From Table 3, we can determine that:
(1) K

increases for diabetics. This means the glucose
1
mass transfer, which is dependent on insulin, is
higher in diabetics than in normals. On the other
hand, since the diabetics have an insufficient supply of insulin, the high level glucose concentration
thus goes to the tissue. Also, the difference of
K 1 in these three cases is not very significant;
therefore, it will not effect the mechanism much.

(2) K 2 decreases from normals to moderate diabetics.
This is the reason why diabetics tire more easily
than normals. Because the smaller the K 2 is the
less glucose transfer to the brain or to the red
cells, especially for mild diabetics.
(3) K

3

increases as the diabetic condition becomes more

serious. From the mechanics, it shows the average
rate of release of glucose to blood from liver or
tissue was increased. It makes the diabetics have
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more glucose in the blood, plasma than in the normals
due to abnormal release of glucose.
(4) K 4 is decreased from normals to moderate diabetics.
This shows the rate of insulin breakdown in plasma
by enzyme in diabetics is lower than in normals.
If K 4 is small, as compareed with normals, the metabolism of glucose in plasma will be slowed down and
causes the concentration of glucose to increase
steadily.
(5) K

5

decreased from top to bottom in Table 3 indicates

that the diabetics do not get sufficient secretion

of insulin by a feedback mechanism coming from the
pancreas as normals. Therefore, the diabetics cannot metabolize the glucose in plasma by using the

extra secretion from the pancreas.
(6) Table 3 also shows that mild diabetics have the
largest value for K 6 . This is a very special situation for us, because it show that mild diabetics
secrete a lot of insulin from β-cells to maintain
constant influe of insulin. This phenomena called
hyperinsulinemia is due to the nature response of
human body for attempting to keep the glucose concentration at normal level. For normals, they do not
need more insulin secretion from

because

other mechanisms work in the normal conditions.
(7) K7 is extremely high in the normal case. We can say
that the feedback mechanism which, due to M 1 (t)
— 29 —

step input, is very sensitive for normals and not
for moderate diabetics. Since the feedback mechanism does not work well in diabetics, the diabetics
will not be able to metabolize the glucose very
effectively.
TABLE 3
Non-obese normal (A), Non-obese mild diabetics (B), and Nonobese moderate diabetics (C)

Subjects

K 3K 4
K2
1
-4 x10 -1 x10 -2
x10 -5 x10
K

K
x10

5

-2

K7
6
x10 -3 x10 -2
K

A

3.59

6.57

0.28

6.18

6.39

0.0096 159.81

B

4.90

2.03

5.40

4.17

5.49

1.01

2.44

C

5.84

3.39

9.35

2.99

0.96

0.16

3.83

(II) Case of Obese normal, Obese mild diabetics, and Obese
moderate diabetics
For obese case, the general discussions of the dynamic
mechanisms are almost the same as we hayed discussed
for non-obese case. However, we notethat K 2 does not
follow the tendency of decrement. K 2 in mild diabetics
is higher than in moderate diabetics. This means the
transportation rate of glucose to the red cells in mild
diabetics is faster than in moderate diabetics. The
other significant changes are K 4 , K 6 , and K 7 . On the
contrary, the non-obese normals and the obese normals
have a lower breakdown rate of insulin by enzyme than
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the obese mild diabetics. And, the parameter K 6 shows
the obese normals have the highest hyperinsulinemia
situation in all cases. Since K 7, the feedback mechanism to secrete the insulin, is much smaller in obese
people than in non-obese people, we can say that the
obese people have more glucose than the non-obese people in blood. Also, from the value of K 6 , it seems that
the efficiency of 3-cells secretion in moderate diabetics cannot work out well.
TABLE 4
Parameter of Obese normal (D), Obese mild diabetics (E), and
Obese moderate diabetics (F)

Subjects

K1

K2

K

3

K

4

K

5

K6

K7

x10 -2

x10 2

x10 -3 x10 2

0.27

4.10

7.94

6.62

266.85

3.40

6.06

4.27

4.81

5.72

84.86

3.09

7.08

2.94

0.99

0.047

38.37

x10 -5

x10 - 4 x10

D

3.07

4.31

E

3.52

F

4.74

-1

-

-

(III) Case of Non-obese normal, and Obese normal
The obese normals transfer less glucose to the tissue
or to the red cells than the non-obese normal. The
average rate of release of glucose into the blood from

the liver are same for both subjects. In regard to
insulin, the insulin breakdown rate by enzyme decreases, and the insulin coming from

— 31 —

or feed-

back mechanism increases for the obese people. The
large difference in K 6 and K 7 , between non-obese normal and obese normal, proves that large accumulation
of insulin which comes from 3-cells or feedback mechanism by M 1 (t) exists in obese normals. Totally, we
might say that the obese normals have more glucose and
insulin than the non-obese normals.
TABLE 5
Parameters of Non-obese normal (A) and Obese normal (D)

Subjects

A

K1

K2

x10 -5 x10 -4

K
x10

3

-1

K

x10

K
-2

x10

5
-2

K6

K

7

x10 -3 x10 -2

3.59

6.57

0.28

6.18

6.39

0.0096 159.8

3.07

4.31

0.27

4.10

7.94

6.62

266.85

(IV) Case of Non-obese mild diabetics and Obese mild diabetics
From Table 6, we see that K 2 in obese mild diabetics
is larger than in non-obese diabetics. So, the tranfer of glucose to the red cells will be larger in the
obese case than in the non-obese case . K5 shows that the
extra secretion of insulin from pancreas in obese mild
diabetics is less than in non-obese mild diabetics.
These are different from the normal people. Generally,
we may have the following discovery:
(1) Mild diabetics have the hyperinsulinemia phenomena

-3

because of the body response for attempting to
lower the glucose concentration.
(2) There are no differences in the rate of insulin
breakdown by enzyme between non-obese mild diabetics and obese diabetics.
(3) Mild diabetics have the ability to metabolize the
extra glucose which is caused by the abnormal
mechanisms of K , K , K 5, and K

4

3

7.

TABLE 6
Parameters of Nonobese mild diabetics (B) and Obese mild
diabetics (E)

Subjects

K

1

K2

x10 -5 x10 -4

K

K

3

x10 -1

x10

K
-2

x10

5

-2

K
K6
7
-2
x10 -3 x10

B

4.90

2.03

5.40

4.17

5.49

1.01

E

3.52

3.40

6.06

4.27

4.80

5.72 84.86

2.44

(V) Gases of Non-obese moderate diabetics and Obese moderate
diabetics
Since the moderate diabetics in serious condition, Table
7 shows that there are no differences in K 22', K 33', K 4'
and K 5 between the nonobese and the obese. All these
in the
7
nonobese mild diabetics is larger than in the nonobese
mechanisms are under abnormal conditions. K

moderate diabetics. That is due to the total effects
fromK2, 4 K5, 6 onK7.TheK 4in o bes i large
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than obese. This is different from normal and mild
diabetics cases. Thus, it means that non-obese moderate
can get more insulin from β-cells than obese moderate
diabetics. Therefore, we can conclude that the obese
moderate diabetics are in the worst condition.
TABLE 7
Parameters of Non-obese moderate diabetics (C) and Obese
moderate diabetics (F)

Subjects

K1

K2

K

3

K

K

5

-2

K

6

K

7

x10 -3 x10 -2

x10 -5 x10 -4 x10 -1

x10 2

x10

C

5.84

3.39

9.35

2.99

9.55

1.63

3.83

F

4.74

3.09

9.08

2.94

9.91

0.47

38.36

(VI) The research studies by Drs. Judith and Richard Wurtman
shows low-carbohydrate diets are doomed to fail for
many overweight people because they upset a chemical
regulator in the brain that triggers a craving for
sweet, bread and starches. When someone eats carbohydrates, insulin is release into the blood. This
raises the body's level of an amino acid called trytophan. In the brain, tryptophan is used to manufacture a chemical called serotonin. This, in turn, turns
off the hunger for carbohydrates.
Referring the research done by Drs. Judith to our
model, we find the obese normal subjects have the most
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strong appetite for carbohydrates after a diet because
they have the highest value of K 5 for extra secretion
of insulin by a glucose feedback mechanism.

TABLE 8
Summary of optimal parameters for differents cases

Subjects

K1

K

2

K

3

K

4

K

5

K

6

K

7

x10 -5 x10 -4 x10 -1 x10 2 x10 2 x10 -3x10-3

Max. Time Max. Time
(G)
of (I)
of
(G)
(I)
mg/ Max. μU/ml Max
100m1

Nonobese

3.59
normals (21)

6.57

0.28

6.18

6.39

0.0096

159.81

Obese
normals (11) 3.07

4.31

0.27

4.10

7.94

6.62

266.85 130 45 253 52

Nonobese
mild diabetics (10)

4.90

2.03

5.40

4.17

5.49

1.01

2.44

188 74 217 88

diabetics(11) 3.52

3.40

6.06

4.27

4.81

5.72

84.86

200 80 222 88

3.39

9.35

2.99

0.96

0.16

3.83

305 100 90 120

3.09

7.08

2.94

0.99

0.047

38.37

320 104 105 105

moderate

Obese mild

Nonobese

dia- 5.84
betics (7)

Obese moderate diabetics 4.74
(7)

118 32 120 44

CHAPTER V
CONCLUSIONS
The mathematical model presented has been a successful
and effective way to average the measure point into several
parameters. Through the comparison of parameters, it has
enabled diagnostic classification, hypothesis testing, and
extension of knowledge of blood glucose dynamics for normals
and, diabetics.
It is believed that this research can be utilized to
determine the effect on the different designed parameters
of the glucose dynamics and also can help to characterize
quantitatively disease states; the model need not even produce
an acceptable description of the empirical data.

CHAPTER VI
RECOMMENDATIONS
Some terms of the mathematical model reprented can be
modified as follow:
(1) K (G)(I) should be K1(G)(I)ads which (I) ads is the
1
concentration of insulin adsorped on the surface of
tissue.
(2)

If (G) is much lower than the fasting glucose concentration (G ), K will not be a constant. K should
3
0
3
increase faster than a constant when (G)-(G 0 'J is a
large negative quantity.

(3) The step function M 1 (t) should be modified as a distribution function.
(4) K (I) should be modified as K (I)(Enzyme).
4
4
may be a function of time and follows the

(Enzyme)

Michaelis-Menten kintics.
(5) K (G) can be expressed as K ((G)-(G 0 )) or a feedback
5
5
control model.
(6)

If (I) is much lower than the fasting insulin concen-

tration (I )K should increase faster than a constant.
0 ' 6
(7) The same studies can be developed for thyroid gland and
iodine balance.

APPENDIX A
C
C
C
C
C

OPTIMIZATION PROGRAM FOR NONLINEAR
SIMULTANEOUS EQUATIONS
REAL LC
INTEGER PR
INTEGER P
INTEGER R
INTEGER C
DIMENSION XX(10,10),XCEN(10,10),XREF(10,10),
1Z(10),XCON(10,10),XEX(10,10)
DIMENSION X(10),E(8),V(8,8),SA(8),D(8),G(8)
1H(8),AL(B),PH(8),A(8,8),B(8,8),BX(8),DA(8),
1VV(8,8),EINT(8),VM(8),Y(10)
COMMON EXP(50,50),TR(50)
DATA ITMAX,IPRINT,L,ALFA,BETA,GAM,ACC,A
1/40,10,7,1.0,0.5,2.0,0.01,0.0001/
DATA M,P,LOOPY,PR,ND,NDATA,NSTEP/ 1 7 7 1
11,0,0,0/
READ (5,35) (E(J),J=1,L)
READ (5,35) (XX(1,J),J=1,L)
FORMAT (7F10.2)
DATA NVAR,NDAT/2,24/
READ (5,45) (Y(J),J=1,NVAR)
FORMAT (2F10.1)
READ (5,43) (EXP(IL,1),IL=1,NDAT)
READ (5,47) (EXP(IL,2),IL=1,NDAT)
FORMAT (8F10.1/8F10.1/8F10.1)
FORMAT (8F10.1/8F10.1/8F10.1)
NP1=L+1
Q=CAA/(L*(2.**.5)))*((L4 1.)**.5 1.)
P1=(AA/(L*(2.**.5)))*((L4.1)**.54 L 1.)
MM=L+1
DO 139 I=2,MM
AP=1.0
DO 121 J=1,L
AP=AP+1
IF (I .EQ. AP) GO TO 135
XX(I,J)=XX(1,J)+D
GO TO 121
XX(I,J)=XX(1,J)+P1
CONTINUE
CONTINUE
IF (ALFA .EQ. 0.) ALFA=1.
IF (BETA +EQ. 0.) BETA=.5
IF (GAM +EQ. 0.) GAM=2.
IF (ACC +EQ. 0.) ACC=0.1
WRITE (6,23)
FORMAT(1H1,10X,28HNELDER AND MEAD OPTIMIZATION)
,

-

35
45
43
47

.

-

-

135
121
139

23
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,

,

,

,

WRITE (6,24)
24 FORMAT(/,2X,10HPARAMETERS)
WRITE (6,25) L,ACC,ALFA,BETA,GAM
25 FORMAT (/,2X,25HNUM OF COEFF OPTIMIZED = ,I2,
14X,11HACCURACY = ,E10.4,/,2X,8HALPHA = r
1E10.4,4X,7HBETA = ,E10.4,4X,8HGAMMA = ,E10.4)
WRITE (6,29)
29 FORMAT (//,10X,16HSTARTING SIMPLEX)
DO 141 I=1,NP1
WRITE (6,28) (I,J,XX(I,J),J=1,L)
28 FORMAT(/,4(2X,2HX(,I2,1H,I2,4H) = v
11PE12.5))
141 CONTINUE
ITR=0
150 DO 155 I=1,NP1
CALL FUNC (I,XX,Z,Y,FNC)
155 CONTINUE
ITR=ITR+1
IF (ITR .GE. ITMAX) GOTO 145
IF (IPRINT) 158,162,158
158 WRITE (6,37) ITR
37 FORMAT (//,2X,17HITERATION NUMBER, 13)
DO 161 J=1,NP1
161 WRITE (6,28) (J,I,XX(J,I),I=1,L)
GO TO 162
162 ZHI=AMAX1(Z(1),Z(2),Z(3),Z(4),Z(5),Z(6) Z(7) Z(8))
ZLO=AMIN1(Z(1),Z(2),Z(3),Z(4),Z(5),Z(6) Z(7) Z(8))
DO 165 I=1,NP1
IF (ZHI .E0. Z(I)) GOTO 171
165 CONTINUE
171 K=I
EN=L
DO 181 J=1,L
SUM=0.
DO 175 I=1,NP1
IF (K +EQ. I) GOTO 175
SUM=SUM+XX(I,J)
175 CONTINUE
181 XCEN(K,J)=SUM/EN
I=K
CALL FUNC (I,XCEN,Z,Y,FNC)
ZCEN=Z(I)
SUM=0.
DO 185 I=1,NP1
IF (K .E0. I) GOTO 185
SUM=SUM-HZ(I)-ZCEN)*(Z(I)-2CEN)/EN
185 CONTINUE
EJ=SORT(SUM)
IF (EJ .1-T. ACC) GOTO 998
DO 191 J=1,1-
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,

,

,

XREF(K,J)=XCEN(K,J )+ALFA*()<CEN(K,J)-XX(K,J))
191 CONTINUE
I=K
CALL FUNC (I,XREF,ZiY,FNC)
ZREF=Z(I)
DO 200 I=1,NP1
IF (ZLO +E04 Z(I)) GOTO 205
200 CONTINUE
205 LL=I
IF (ZREF +LE. Z(LL)) GOTO 241
DO 207 I=1,NP1
IF (ZREF ,LT~ Z(I)) GOTO 208
207 CONTINUE
GO TO 215
208 DO 211 J=1,1_
211 XX(K,J)=XREF(K,J)
GO TO 150
215 DO 221 J=1,L
221 XCON(K,J)=XCEN(K,J)+BETA*(XX(K J) XCEN(K J))
I=K
CALL FUNC (I,XCON,Z,Y,FNC)
ZCON=Z(I)
IF (ZCON *LT. Z(K)) GOTO 231
DO 225 J=1,L
DO 225 I=1,NP1
225 XX(I,J)=(XX(I,J)+XX(LL,J))/2.
GO TO 150
231 DO 235 J=1,L
235 XX(K,J)=XCON(K,J)
GO TO 150
241 DO 245 J=1,1_
245 XEX(K,J)=XCEN(K,J)+GAM*(XREF(K,J) XCEN(K J))
I=K
CALL FUNC (I,XEX,Z,Y,FNC)
ZEX=Z(I)
IF (ZEX .LT. Z(LL)) GOTO 255
DO 251 J=1,L
251 XX(K,J)=XREF(K,J)
GO TO 150
255 DO 261 J=1,L
261 XX(K,J)=XEX(K,J)
GO TO 150
145 WRITE (6,10) ITMAX
10 FORMAT (///,10X,20HDID NOT CONVERGE IN,
1I5,11HITERATIONS+)
998 WRITE (6,39) ZLO
39 FORMAT (//,2X,21HOPTIMUM VALUE OF F = ,E16.8)
WRITE (6,19)
19 FORMAT (//,2X,'OPTIMUM VALUE OF VARIABLE')
DO 301 I=1,L
,

-

-

,

,

301 WRITE (6,26) I,)(X(NPl,I)
26 FORMAT (/,2X,2HX(,I2,4H) = ,1PE16.8)
WRITE (6,21) EJ
21 FORMAT (/,2X,'EJ = ',F10.5)
DO 610 J=1,L
610 X(J)=XX(NPl,J)
WRITE (6,13)
13 FORMAT (1H1,10X,'ROSENBROCK HILLCLIMB PROCEDURE')
C
C
IF (ND-1) 30,20,30
20 DO 300 KA=1,NDATA
READ (NI,2) DA(KA)
2 FORMAT (1E10.4)
300 CONTINUE
C
30 LAP=PR-1
LOOP=0
ISW=0
INIT=0
KOUNT=0
TERM=0.0
DELY=0.001
F1=0.0
NPAR=NDATA
N=L
DO 40 K=1,L
40 AL(K)=(CH(X,DA,N,NPAR,K) CG(X,DA,N,NPAR,
1K))*0.0001
DO 60 I=1,P
DO 60 J=1,P
V(I,J)=0.0
IF (I-J) 60,61,60
61 V(I,J)=0.0005
60 CONTINUE
DO 65 KK=1,P
EINT(KK)=E(KK)
65 CONTINUE
-

C
C
1000 DO 70 J=l,P
IF (NSTEP ,EQ. 0) E(J)=EINT(J)
SA(J)=2.0
70 D(J)=0.0
FBEST=F1
80 I=1
IF (INIT .EQ. 0) GOTO 120
90 DO 110 K=1,P
110 X(K)=X(K)+E(I)*V(I,K)
DO 50 K=1,L
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C
C

C
C

50 H(K)=F0
120 F1=F(X,NrY,FNC)
F1=M*F1
IF (ISW .EQ. 0) F0=F1
ISW=1
IF (ABS(FBEST-F1)-DELY) 122,122,125
122 TERM=1.0
GO TO 450
125 CONTINUE

C

C

J=1
130 XC=CX(X,DA,N,NPAR,J)
LC=CG(X,DA,N,NPAR,J)
UC=CH(X,DA,N,NPAR,J)
IF (XC .LE. LC) GOTO 420
IF (XC .GE. UC) GOTO 420
IF (F1 .LT. FO) GOTO 420
IF (XC .LT. LC+AL(J)) GOTO 140
IF (XC .GT. UC-AL(J)) GOTO 140
H(J)=F0
GO TO 210

C
C
C

C
C

C

140 CONTINUE
BW=AL(J)
IF (XC .LE. LC .0R+ UC .LE. XC)
1GOTO 159
IF (LC .LT. XC .AND. XC .LT. LC+BW)
1GOTO 160
IF (UC-BW .LT. XC .AND. XC .LT. UC)
1GOTO 170
PH(J)=1.0
GO TO 210
159 PH(J)=0.0
GO TO 190
160 PW=(LC+BW-XC)/BW
GO TO 180
170 PW=(XC-UC+BW)/BW
180 PH(J)=1.0-(3.0*PW)+(4.0*PW*PW)1(2.0*PW*PW*PW)
190 F1=H(J)+(F1-H(J))*PH(J)
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C

C

210 CONTINUE
IF (J .EQ. L) GOTO 220
J=J+1
GO TO 130
220 INIT=1
IF (F1 .LT. FO) GOTO 420
D(I)=D(I)+E(I)
E(I)=3.0*E(I)
F0=F1
IF (SA(I) +GE. 1.5) SA(I)=1.0

C
230 DO 240 JJ=1,P
IF (SA(JJ) .GE. 0.5) GOTO 440
240 CONTINUE
C
C

AXES ROTATION

250

265
260

280

310

DO 250 R=1,P
DO 250 C=1,P
VV(C,R)=0.0
DO 260 R=1,P
KR=R
DO260C=1,P
DO 265 K=KR,P
VV(R,C)=D(K)*V(K,C)+VV(R,C)
B(R,C)=VV(R,C)
BMAG=0.0
DO 280 C=1,P
BMAG=BMAG+(B(1,C)*B(1,C))
CONTINUE
BMAG=SQRT(BMAG)
BX(1)=BMAG
DO 310 C=1,P
V(1,C)=B(1,C)/BMAG

C
C

DO 390 R=2,P
IR=R-1
DO 390 C=1,P
SUMVM=0.0
DO 320 KK=l,IR
SUMAV=0.0
DO 330 KJ=1,P
330 SUMAV=SUMAV+VV(R,KJ)*V(KK,KJ
320 SUMVM=SUMAV*V(KK,C)+SUMVM
390 B(R,C)=VV(R,C)-SUMVM
DO 340 R=2,P
BBMAG=0.0
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DO 350 K=1,P
350 BBMAG=BBMAG+B(R,K)*B(R,K)
BBMAG=SQRT(BBMAG)
DO 340 C=1,P
340 V(R,C)=B(R,C)/BBMAG
LOOP=LOOP+1
LAP=LAP+1
IF (LAP .EQ. PR) GO TO 450
GO TO 1000
420 IF (INIT .EQ. 0) GOTO 450
DO 430 IX=1,P
430 X(IX)=X(IX)-E(I)*V(I,IX)
E(I)=-0.5*E(I)
IF (SA(I) .LT. 1.5) SA(I)=0.0
GO TO 230
440 CONTINUE
IF (I .E0. P) GOTO 80
1=1+1
GO TO 90
C
450 WRITE (6,3)
3 FORMAT (//,2,5HSTAGEP8X,8HFUNCTION,12X,
18HPROGRESS,9X,16HLATERAL PROGRESS)
WRITE (6,4) LOOP,FO,BMAG,BBMAG
4 FORMAT (1H,I5,3E20.8)
WRITE (6714) KOUNT
14 FORMAT (/,2X,'NUMBER OF FUNCTION EVALUATIONS = ',I8)
WRITE (6,5)
5 FORMAT (/'2X,25HVALUES OF X AT THIS STAGE)
C
C
C

PRINT CURRENT VALUES OF X
WRITE (6,6) (JM,X(JM),JM=1,P)
6 FORMAT (/,2(2X,2HX(,I12,4H) = ,1PE14.6,4X))

C
LAP=0
IF (INIT .EQ. 0) GOTO 470
IF (TERM ,EQ. 1.0) GOTO 480
IF (LOOP .GE. LOOPY) GOTO 480
GO TO 1000
C
470
7
480
490
8

WRITE (6,7)
FORMAT (///,2X,'THE START POINT MUST NOT VIOLATE')
CONTINUE
WRITE (6,8)
FORMAT (///,2X,'FINAL DIRECTION VECTOR MATRIX')
DO 500 -1=1,P
500 WRITE (6,9) (J,I,V(J,I),I=1,P)

-45-

9 FORMAT (/,2(2X,2HV(,I2,1H, ,I2,4H) =
1F10.8,4X))
WRITE (6,11)
11 FORMAT (//,2X,16HFINAL STEP SIZES)
WRITE (6,12) (J,E(J),J=1,P)
12 FORMAT (/,2(2X,2HS(,I1,4H) = ,F10.8,
14X))
F7=F(X,N,Y,FNC)
DO 540 I=1,NDAT
540 WRITE (6,17) TR(I),FNC(I,1),FNC(I,2)
17 FORMAT (/,2)(,'T = ',F6.2,8X,
1'G = ',F7.2,8X, 'I = ',F7.2)
STOP
END
FUNCTION F(XE,IA,Y,FNC)
DIMENSION XE(10),Y(10),G(10),FNC(50,50)
COMMON EXP(50,50),TR(50)
DATA NDAT,TMAX,H,KOUNT,NVAR,CMAX/24,240. , 1.,0,2 , 75./
INTEGER RUNGE
T=0.
J=0.
SUM=0.
T1=0.
C
CALL ON THE FOURTH-ORDER RUNGE-NUTTA NUMERICAL METHOD
15 CALL RUNKU(RUNGE,2Y,G,T,H)
C
WHENEVER RUNGE=1 COMPUTE DERIVATIVE
IF (RUNGE .NE. 1) GOTO 82
IF (T-CMAX) 45,45,46
45 G(1)=-(XE(1)*Y(1)*Y(2))-(XE(2)*Y(1))+XE(3)+1.8
G(2)=-(XE(4)*Y(2))+(XE(5)*Y(1))+XE(6)+XE(7)
GO TO 15
46 G(1)=-(XE(1)*Y(1)*Y(2))-(XE(2)*Y(1))+XE(3)
G(2)=-(XE(4)*Y(2))+(XE(5)*Y(1))+XE(6)
GO TO 15
82 IF (T-TMAX) 90'90,95
90 DO 106 M=1,241,10
T1=M-1.
IF (T-T1) 15,53,106
106 CONTINUE
53 J=J+1
TR(J)=T
FNC(J,1)=Y(1)
FNC(J,2)=Y(2)
GO TO 15
95 DO 100 IL=1,NDAT
A1=EXP(IL,1)
B1=FNC(IL,1)
C1=(A1-B1)**2
A2=EXP(IL,)
B2=FNC(IL,2)
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100
140
10
19
11
120

C
C

C2=(A2-B2)**2
SUM=SUM+(C1+C2))
CONTINUE
F=SUM
IF (KOUNT-25.) 120,140,140
WRITE (6,10) KOUNT
FORMAT (ir2X,'ITERATION NUMBER = ',I8)
WRITE (6,19) F
FORMAT (/,2X,'FUNCTION = ',F12.1)
WRITE (6,11) (J,XE(J),J=1,IA)
FORMAT (/,4(4X,2HX('I1,4H) = ,1PE14.6))
KOUNT=KOUNT+1
RETURN
END
FUNCTION CX (X,DA,N,NPAR,K)
DIMENSION X(N),DA(NPAR)
CX=X(K)
RETURN
END

FUNCTION CO (X,DA,N,NPAR,K)
DIMENSION X(N),DA(NPAR)
CG=0.0
RETURN

C
C

END
FUNCTION CH (X,DA,N,NPAR,K)
DIMENSION X(N),DA(NPAR)
GO TO (1,2,3,4,5,6,7),K
1 CH=X(1)*10.
GO TO 9
2 CH=X(2)*10.
GO TO 9
3 CH=X(3)*10.
GO TO 9
4 CH=X(4)*10.
GO TO 9
5 CH=X(5)*10.
GO TO 9
6 CH=X(6)*10.
GO TO 9
7 CH=X(7)*10.
9 RETURN
END
SUBROUTINE RUNKU(RUNGE,N1,Y,G,W,H2)

INTEGER RUNGE

_4 7

I
2
22

3
33
4
44

5
55

DIMENSION PHI(50),SAVEY(50),Y(10),G(10)
DATA M1/0/
M1=M1+1
GO TO (1,2,3,4,5),M1
RUNGE=1
RETURN
DO 22 J=1,N1
SAVEY(J)=Y(J)
PHI(J)=G(J)
Y(J)=SAVEY(J)+0.5*H2*G(J)
W=W+0.5*H2
RUNGE=1
RETURN
DO 33 J=1,N1
PHI(J)=PHI(J)+2.0*G(J)
Y(J)=SAVEY(J)+0.5*H2*G(J)
RUNGE=1
RETURN
DO 44 J=1,N1
PHI(J)=PHI(J)+2.0*G(J)
Y(J)=SAVEY(J)4442*G(J)
W=W+0.5*H2
RUNGE=1
RETURN
DO 55 J=1,N1
Y(J)=SAVEY(J)+(PHI(J)+G(J))*H2/6.
M1=0
RUNGE=0
RETURN
END
SUBROUTINE FUNC (I,XX,Z,Y,FNC)
DIMENSION XX(10,10),Z(10),F(10),Y(10) FNC(50 50)
COMMON EXP(50,50),TR(50)
DATA NDAT,TMAX,H,NVAR,CMAX/24,240.,1.,2,75./
INTEGER RUNGE
X1=XX(I,1)
X2=XX(I,2)
X3=XX(I,3)
X4=XX(I,4)
X5=XX(I,5)
X6=XX(I,6)
X7=XX(I,7)
T=0.
J=0
SUM=0.
T1=0.
CALL ON THE FOURTH-ORDER RUNGE-KUTTA NUMERICAL METHOD
CALL RUNKU(RUNGE,2,Y,F,T,H)
WHENEVER RUNGE=1 COMPUTE DERIVATIVE VALUE
IF (RUNGE .NE. 1) GOTO 82
,

C
C

15

,
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IF (T-CMAX) 45,45,46
45 F(1)=-(X1*Y(1)*Y(2))-(X2*Y(1))+X3+1+80
F(2)=-(X4*Y(2))+0(5*Y(1))+X60(7
GO TO 15
46 F(1)=-0(1*Y(1)*Y(2))-(X2*Y(1))+X3
F(2)=-(X4*Y(2))+(X5*Y(1))+X6
GO TO 15
82 IF (T-TMAX) 90,90,95
90 DO 106 M=1,241,10
T1=M-1.
IF (T-T1) 15,53,106
106 CONTINUE
53 J=J+1
TR(J)=T
FNC(J,1)=Y(1)
FNC(J,2)=Y(2)
GO TO 15
95 DO 100 L=1,NDAT
A1=EXP(L,1)
B1=FNC(L,1)
C1=(A1-B1)**2
A2=EXP(L,2)
B2=FNC(L,2)
C2=(A2-B2)**2
SUM=SUM+(C1+C2)
100 CONTINUE
Z(I)=SUM
RETURN
END
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normal s
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FIG. 17. The last twenty values of K of nonobese
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FIG. 18. The last twenty values of K
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FIG. 19. The last twenty values of K 5 of nonobese
normal subjects
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FIG. 20. The last twenty values of K 6 of nonobese
normal subjects
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FIG. 21. The last twenty values of K 7 of nonobese
normal subjects
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